Samsung Biologics Co.,Ltd. (KRX: 207940)

Samsung Biologics Co.,Ltd. Market Cap

Samsung Biologics Co.,Ltd. has a market cap or net worth of 73.74 trillion as of October 14, 2024. Its market cap has increased by 41.14% in one year.

• Market Cap: 73.74T
• Enterprise Value: 73.85T
• Revenue: 4.21T
• Ranking: n/a
• PE Ratio: 71.70
• Stock Price: 1,024,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics Co.,Ltd.'s market cap has increased from 9.53T to 73.74T, an increase of 673.91%. That is a compound annual growth rate of 29.47%.

Market Cap History

Date	Market Cap	% Change
Oct 11, 2024	72.88T	34.74%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	54.65T	90.76%
Dec 30, 2019	28.65T	12.03%